Research progress on the application of G31P for prevention and control of human diseases
G31P (CXCR1/2 antagonist of human recombinant), a kind of low molecular weight protein, can compete with IL-8 and combine with its receptors, leading to the loss of biological activities of IL-8 and its receptors, blocking the chemotaxis of neutrophils and nonspecific immune response, so as to control the devel-opment of the host inflammation. In recent years, studies found that IL-8 and its receptors were highly ex-pressed in diseases such as cancer, cardiovascular disease and inflammation disease, as well as trichinosis, schistosomiasis. The application of G31P to control inflammation development in order to achieve the purpose of prevention and treatment of disease has become one of hot topics in the study of scholars at home and abroad.
NETL
NSTL
万方数据
